PROGRAMME

Day 2 (Friday) centers around lectures covering Locally Advanced Prostate Cancer, Artificial Intelligence, and Imaging Recurrence. Similar to Day 1, there will be Case-Based Presentations (CBP) in smaller groups led by international experts, addressing topics like Active Surveillance and AI. An MDT case-discussion will focus on T, N, and M-staging, as well as radiotherapy. The day concludes with workstation-based Interactive Hands-on Trainings (HOT). Please ensure you have your laptop with you.

Day 3 (Saturday) features a half-day program with parallel sessions. Participants can choose between lectures on the Organization of Diagnostic Prostate Cancer Care and Screening, or engage in CBP–workshops, MTD–presentations, or HOT–workshops that cover all previously presented topics.

Friday

27th June Thursday

08:00 – 09:00	Registration, coffee
08:45 – 08:50	Welcome Jelle. O. Barentsz, Nijmegen Ivo Schoots, Rotterdam
08:50 – 09:40	Prostate MRI in diagnosis Jelle. O. Barentsz, Nijmegen Geert Villeirs, Ghent Prostate histology and pathology: What is “significant” prostate cancer? Arno van Leenders, Rotterdam Prostate MRI: What abnormalities can we expect to see? Geert Villeirs, Gent PI-RADS v2.1: How do we classify prostate abnormalities? Jelle Barentsz, Nijmegen Discussion
09:40 – 10:30	MRI challenges: Benefit/harms, acquisition, and quality Tristan Barrett, Cambridge Ivo Schoots, Rotterdam MRI-pathway: What are de benefits and harms? Ivo Schoots, Rotterdam MRI quality: How do we acquire a high-quality scan? fast MRI – can we speed up acquisition? Tom Scheenen, Nijmegen MRI quality: What is PI-QUAL v1.0 and v2.0 classification? Why is it necessary? How can we assure quality in daily practice? Tristan Barrett, Cambridge Discussion
10:30 – 11:00	Coffee/Tea break
11:00 – 11:50	MRI challenges: Contrast, PI-RADS 3, interobserver varaibility, ADC quantification Jonathan Richenberg, Brighton Tom Scheenen, Nijmegen MRI and contrast: When do we need contrast? Jonathan Richenberg, Brighton MRI and interobserver variability: Why and how can we reduce false positives? Raphaelle Renard-Penna, Paris MRI and PI-RADS 3 cases: How can we reduce indeterminate cases? Lars Schimuller, Dusseldorf MRI: What are the challenges in ADC metric quantification? Tom Scheenen, Nijmegen Discussion
11:50 – 12:40	MRI challenges: Risk assessment, biopsy, histology analysis Philippe Puech, Lille Ivo Schoots, Rotterdam Pre-biopsy risk: How can we use MRI in risk assessment? Roderick van de Bergh, Rotterdam Biopsy approach: How can we use MRI in guiding biopsy strategy Cognitive, fusion, or in-bore biopsy? Philippe Puech, Lille Biopsy challenges: How can we reduce false negatives? Olivier Rouviere, Lyon Biopsy analyses: How do we use aggregated scoring? Arno van Leenders, Rotterdam
12:40 – 13:40	Industry Lunch Symposium
Parallel session / workshops
15:45 – 16:15	Coffee/Tea break
16:15 – 17:05	MRI in Active Surveillance Francesco Giganti, London Pim van Leeuwen, Amsterdam Surveillance: What are the indications, adoption, and risk assessment? Francesco Sanguedolce, Barcelona Surveillance: How do we use PRECISE v1.0 in monitoring and guiding patient management? Raphaelle Renard-Penna, Paris Surveillance: Are we ready for MRI-based active monitoring (no/delayed biopsy)? Pim van Leeuwen, Amsterdam PRECISE international collaboration: What are the results of v1.0 international study and consensus meeting v2.0? Francesco Giganti, London Discussion
17:05 – 17:15	Summary and closing Jelle Barentsz, Nijmegen Ivo Schoots, Rotterdam

13:40 – 14:40 Parallel session / workshops
Room 1: Copijnzaal	RW 1a	Radiological workshop – Prostate MRI: cases (5-10) on PI-RADS assessment Vibeke Logager, Copenhagen Andrea Ponsiglione, Napels
Room 2: Springerzaal	RW 2a	Radiological workshop – Prostate MRI: cases (5-10) on notorious pitfalls and tricks Kai (JC) Vilanova, Girona Martina Pecoraro, Rome
Room 3: Zocherzaal	HOT 1	Hands-on training (a) (24 people) Marloes van der Leest, Nijmegen Ailin Dehganpour, Rome
Room 4: Tersteegzal	HOT 2	Hands-on training (b) (24 people) Patrick Zamecnik, Nijmegen George Agrotis, Larissa
Room 5: Willem Pijperzaal	MDT 1a	Multi-disciplinary (MDT) team workshop – MRI and biopsy: Case-discussion on risk stratification and biopsy decision Olivier Rouviere, Lyon (chair) Roderick van de Bergh, Rotterdam Francesco Sanguedolce, Barcelona Floris Pos, Amsterdam Arno van Leenders, Rotterdam
Room 6: Johan de Meersterzaal	RW 3a	Radiological workshop – MRI quality: cases (5-10) on PI-QUAL in daily practice Tristan Barrett, Cambridge Maarten de Rooij, Nijmegen
Room 7: Hans Kazànzaal	RW 4a	Radiological case-based workshop – MRI challenges: cases on indeterminate scans Geert Villeirs, Gent Joe Busch, USA
14:40 – 14:45		Change Rooms
14:45 – 15:45 Parallel session / workshops
Room 1: Copijnzaal	RW 1b	Radiological workshop – Prostate MRI: cases (5-10) on PI-RADS assessment Vibeke Logager, Copenhagen Andrea Ponsiglione, Napels
Room 2: Springerzaal	RW 2b	Radiological workshop – Prostate MRI: cases (5-10) on notorious pitfalls and tricks Kai (JC) Vilanova, Girona Martina Pecoraro, Rome
Room 3: Zocherzaal	HOT 3	Hands-on training (a) (24 people) Marloes van der Leest, Nijmegen Ailin Dehganpour, Rome
Room 4: Tersteegzal	HOT 4	Hands-on training (b) (24 people) Patrick Zamecnik, Nijmegen George Agrotis, Larissa
Room 5: Willem Pijperzaal	MDT 1b	Multi-disciplinary (MDT) team workshop – MRI and biopsy: Case-discussion on risk stratification and biopsy decision Olivier Rouviere, Lyon Roderick van de Bergh, Rotterdam Francesco Sanguedolce, Barcelona Floris Pos, Amsterdam Arno van Leenders, Rotterdam
Room 6: Johan de Meersterzaal	RW 3b	Radiological workshop – MRI quality: cases (5-10) on PI-QUAL in daily practice Tristan Barrett, Cambridge Maarten de Rooij, Nijmegen
Room 7: Hans Kazànzaal	RW 4b	Radiological case-based workshop – MRI challenges: cases on indeterminate scans Geert Villeirs, Gent Joe Busch, USA

28th June Friday

08:00 – 09:00	Registration, coffee
08:30 – 08:35	Welcome Jelle. O. Barentsz, Nijmegen Ivo Schoots, Rotterdam
08:35 – 09:25	Imaging in locally advanced prostate cancer: T-staging and treatment decisions Geert Villiers, Gent Henk van der Poel, Amsterdam MRI and T-staging: How and why should we report? Geert Villeirs, Gent PSMA PET-CT in T-staging: How good are we? What are indiications? Is there a role for PSMA PET/MRI? Lisa Tarlinton, Sydney MRI, T-staging, and risk models: how can we identify increased risk of T3 and N/M disease for treatment decisions? Henk van der Poel, Amsterdam MRI and imaging-guided radiation: What is GTV, CTV, and PTV? what are the advantages of MR-Linac (T3?)? Is focal boosting ready for Prime-Time? Uulke van de Heide, Amsterdam Discussion
09:25 – 10:25	Imaging in locally advanced prostate cancer: N/M-staging and treatment decisions Giueseppe Petralia, Milan James Nagarajah, Dusseldorf N/M-staging: what information do we need for treatment decisions: ePLND, pelvic IMRT, ADT? Pim van Leeuwen, Amsterdam MRI whole-body and N/M-staging: What is the added value and what are the key issues? Giueseppe Petralia, Milan MRI USPIO contrast and N-staging by: What are the indications for this next generation imaging modality? Patrik Zamecnik, Nijmegen PSMA PET-CT and N/M-staging: what are the indications? benefits for treatment decision? Theranostics? Lisa Tarlinton, Sydney Theranostics in prostate cancer, bridging diagnostics with treatment – what are the indications and how to organize/approach? James Nagarajah, Dusseldorf Discussion
10:25 – 11:00	Coffee/Tea break
Parallel session / workshops
13:05 – 14:00	Industry Lunch Symposium
14:00 – 14:50	Biochemical recurrence in prostate cancer Valeria Panebianco, Rome Jurgen Futterer, Nijmegen BCR and PSA persistence: what are the criteria, what is the diagnostic and monitoring work-up? salvage treatment options? Tobias Maurer, Hamburg BCR and MR: What is structured reporting following PI-RR? Valeria Panebianco, Rome BCR and PSMA-PET: What are the changes in treatment decisions? Lisa Tarlinton, Sydney Imaging post focal treatment: how should we interpret? Jurgen Futterer, Nijmegen Discussion
14:50 – 16:00	AI/CAD software in prostate cancer diagnosis Anwar Padhani, London Derya Yakar, Groningen AI: What are the essentials/basics in AI/CAD tools in MRI assessment? Renato Cuocolo, Salerno AI: What are the current CE-marked AI/CAD tools in MRI assessment? Industry pitches on prostate MRI/CAD systems AI: What are the challenges regarding tools variability, generalizabilty and, necessary validation? Derya Yakar, Groningen AI: What are the challenges regarding target population, cancer prevalence, and diagnostic performance? Tobias Penzkofer, Berlin AI: What do you need to think before you buy? Anwar Padhani, London Discussion
16:00 – 16:30	Coffee/Tea break
16:30 – 17:20	AI perspectives from development to implementation Jonathan Richenburg, Brighton Maarten de Rooij, Nijmegen AI: industries challenges: How to coop with constantly improving, and commercial, ethical, and legal issues? Jelle Barentsz, Nijmegen AI: radiology perspectives: How does the future radiologist look like? Derya Yakar, Groningen AI: How should the radiological community guide AI companies? Jonathan Richenburg, Brighton AI: What are the assets and preliminary outcomes of the PICAI challenge initiative? Maarten de Rooij, Nijmegen Discussion
17:20 – 17:30	Summary and closing Jelle Barentsz, Nijmegen Ivo Schoots, Rotterdam

11:00 – 12:00 Parallel session / workshops
Room 1: Copijnzaal	MDT 2a	Multidisciplinary team workshop – Imaging and staging: cases on T-staging and treatment decision (surveillance / surgery) Geert Villiers, Gent Lisa Tarlington, Sydney Henk van der Poel, Amsterdam
Room 2: Springerzaal	MDT 3a	Multidisciplinary team workshop – Imaging and staging: cases on N/M-staging and treatment decision (surgery/radiation/systemic treatment) Giueseppe Petralia, Milan (chair) (rad) James Nagarajah, Dusseldorf (nuc) Pim van Leeuwen, Amsterdam (uro)
Room 3: Zocherzaal	HOT 5	Hands-on training (a) (24 people) Sam Whitey, London Margriet van Dljk, Amsterdam
Room 4: Tersteegzal	HOT 6	Hands-on training (b) (24 people) Matthias Roethke, Heidelberg Thierry Boellaard, Amsterdam
Room 5: Willem Pijperzaal	MDT 4a	Multidisciplinary team workshop – Imaging and radiation: cases on indication, GTV/CTV, and focal boosting (radiation) Floris Pos, Amsterdam Olivier Rouviere, Lyon Patrik Zamecnik, Nijmegen Harm van Melick, Utrecht Uulke van der heide, Amsterdam
Room 6: Johan de Meersterzaal	RW 5a	Radiological case-based workshop – MRI in active surveillance: cases on PRECISE v2.0 assessment Francesco Giganti, London Raphaelle Renard-Penna, Paris
Room 7: Hans Kazànzaal	RW 6a	Radiological case-based workshop – AI / CAD systems and MRI: cases on current vendors Tobias Penzkofer, Berlin Jonathan Richenberg, Brighton Renato Cuocolo, Salerno
12:00 – 12:05		Change Rooms
12:05 – 13:05 Parallel session / workshops
Room 1: Copijnzaal	MDT 2b	Multi-disciplinary team workshop – Imaging and staging: cases on T-staging and treatment decision (surveillance / surgery) Geert Villiers, Gent Lisa Tarlington, Sydney Henk van der Poel, Amsterdam
Room 2: Springerzaal	MDT 3b	Multi-disciplinary team workshop – Imaging and staging: cases on N/M-staging and treatment decision (surgery/radiation/systemic treatment) Giueseppe Petralia, Milan James Nagarajah, Dusseldorf Pim van Leeuwen, Amsterdam
Room 3: Zocherzaal	HOT 7	Hands-on training (a) (24 people) Sam Whitey, London Margriet van DIjk, Amsterdam
Room 4: Tersteegzal	HOT 8	Hands-on training (b) (24 people) Thierry Boellaard, Amsterdam Matthias Roethke, Heidelberg
Room 5: Willem Pijperzaal	MDT 4b	Multi-disciplinary team workshop – Imaging and radiation: cases on indication, GTV/CTV, and focal boosting (radiation) Floris Pos, Amsterdam Patrik Zamecnik, Nijmegen Harm van Melick, Utrecht Uulke van der heide, Amsterdam
Room 6: Johan de Meersterzaal	RW 5b	Radiological case-based workshop – MRI in active surveillance: cases on PRECISE v2.0 assessment Francesco Giganti, London Raphaelle Renard-Penna, Paris
Room 7: Hans Kazànzaal	RW 6b	Radiological case-based workshop – AI / CAD systems and MRI: cases on current vendors Tobias Penzkofer, Berlin Jonathan Richenberg, Brighton Renato Cuocolo, Salerno

29th June Saturday

08:00 – 09:00	Registration, coffee
08:45 – 08:50	Welcome Jelle Barentsz, Nijmegen Ivo Schoots, Rotterdam
08:50 – 09:40	Building prostate cancer networks / units Chris Bangma, Rotterdam Mara Blonden-Hidding, Amsterdam Andros Clinics (NL): What are key business factors in high-volume cancer diagnosis? Domien Debruyne, Andros, Arnhem Center of Early Diagnosis (EU): How can we drive research in the field of early diagnosis? or how is healthcare on prevention medicine insured? Mara Blonden-Hidding, Amsterdam Martini Klinik Hamburg: Centralization of diagnostic care – What lessons can we learn from treatment? Tobias Maurer, Hamburg Prostate cancer networking in the Netherlands: What are the pros and cons of network medicine? Chris Bangma, Rotterdam Discussion
09:40 – 09:45	Change rooms
09:45 – 10:35	Certification and accreditation in prostate cancer diagnosis / screening Philippe Puech, Lille Jeroen Veltman, Hengelo Why is there a need for radiological certification and accreditation? What are the developments? Philippe Puech, Lille What lessons can we learn from breast cancer diagnostic/screening units on certification and accreditation regarding quality assessment? Jeroen Veltman, Hengelo Voluntary ESUR prostate MRI examination: A step towards certification? Geert Villiers, Gent Discussion
10:35 – 11:00	Coffee/Tea break
11:00 – 11:50	Prostate cancer screening Anwar Padhani, London Hein van Poppel, Brussels Prostate cancer screening: What is the patient perspective? Erik Briers, UOMO, EAU guidelines Prostate cancer screening: What are the European developments? (EU beating cancer plan, PRAISE-U) Hein van Poppel, Brussels Breast cancer screening: What are the similarities/differences with prostate cancer? Reflecting on initial results from MRI based screening studies (in Sweden/Germany/UK) Jeroen Veltman, Hengelo Prostate cancer screening: What are challenges for MRI implementation? Anwar Padhani, London Discussion
11:50 – 11:55	Change rooms
11:55 – 12:50	The role of the GP in the prostate cancer pathway Philippe Puech, Lille Marco Blanker, Groningen What are the challenges for the GP when a patient asks for a PSA-workup? MRI-indication and prescription by GP or urologist? (GP opinion) Marco Blanker, Groningen MRI-indication and prescription by urologist or GP? What are criteria for high-quality MRI and where to find? (Radiologist opinion) Philippe Puech, Lille How can prostate cancer risk be stratified? MRI-indication and prescription by urologist or GP? (Urologist opinion) Harm van Melick, Nieuwegein What are the challenges for the GP, regarding cancer negative men, following urology to GP referal? Marco Blanker, Groningen Discussion
12:50 – 13:00	Summary and closing Jelle Barentsz, Nijmegen Ivo Schoots, Rotterdam
13:00 – 14:00	Lunch

08:50 – 09:40 Parallel session / workshops
Room 3: Zocherzaal	HOT 9	Hands-on training (a) (24 people) Marloes van der Leest, Nijmegen George Agrotis, Larissa
Room 4: Tersteegzal	HOT 10	Hands-on training (b) (24 people) Valeria Panebianco, Rome Margriet van Dljk, Amsterdam
Room 1: Copijnzaal	MDT 1c	Multi-disciplinary team workshop – MRI and biopsy: Case-discussion on risk stratification and biopsy decision Francesco Sanguedolce, Barcelona Jelle Barentsz, Nijmegen Jolique van Ipenburg, Nijmegen
Room 6: Johan de Meersterzaal	RW 1c	Radiological case-based workshop – Prostate MRI: cases on PI-RADS assessment Vibeke Logager, Copenhagen Andrea Ponsiglione, Napels
Room 7: Hans Kazànzaal	RW 2c	Radiological case-based workshop – Prostate MRI: Cases on notorious pitfalls and tricks Kai (JC) Vilanova, Girona Martina Pecoraro, Rome
09:40 – 09:45		Change Rooms
09:45 – 10:35 Parallel session / workshops
Room 3: Zocherzaal	HOT 11	Hands-on training (24 people) Marloes van der Leest, Nijmegen; Ailin Deghanpour, Rome
Room 4: Tersteegzal	HOT 12	Hands-on training (24 people) Valeria Panebianco, Rome Thierry Boellaard, Amsterdam
Room 1: Copijnzaal	RW 3c	Radiological case-based workshop – MRI quality: cases on PI-QUAL in daily practice Tristan Barrett, Cambridge Maarten de Rooij, Nijmegen
Room 6: Johan de Meersterzaal	RW 4c	Radiological case-based workshop – MRI challenges: cases on indeterminate scans Geert Villeirs, Gent Matthias Roethke, Heidelberg
Room 7: Hans Kazànzaal	RW 7a	Radiological case-based workshop – PSMA PET/CT: cases in high-risk men or indeterminate MRI cases Lisa Tarlington, Sydney Andre Vis, Amsterdam
10:35 – 11:00		Coffee/Tea break
11:00 – 11:50 Parallel session / workshops
Room 3: Zocherzaal	HOT 13	Hands-on training (24 people) Patrik Zamnecik, Nijmegen Malgorzata Deregowska-Cylke, Warsaw
Room 4: Tersteegzal	HOT 14	Hands-on training (24 people) Derya Yakar, Groningen Sam Whitey, London
Room 1: Copijnzaal	RW 5c	Radiological case-based workshop – MRI in active surveillance: cases on PRECISE v2.0 assessment Francesco Giganti, London Kai (JC) Vilanova, Girona
Room 6: Johan de Meersterzaal	RW 6c	Radiological case-based workshop – AI / CAD systems and MRI: Cases on current vendors Tobias Penzkofer, Berlin Jonathan Richenberg, Brighton Renato Cuocolo, Salerno
Room 7: Hans Kazànzaal	RW 7c	Radiological case-based workshop – PSMA PET/CT: Cases in high-risk men or indeterminate MRI cases Lisa Tarlington, Sydney Andre Vis, Amsterdam
11:50 – 11:55		Change rooms
11:55 – 12:45 Parallel session / workshops
Room 3: Zocherzaal	HOT 15	Hands-on training (25 people) Andrea Ponsiglione, Napels Malgorzata Deregowska-Cylke , Warsaw
Room 4: Tersteegzal	HOT 16	Hands-on training (25 people) Derya Yakar, Groningen Sam Whitey, London
Room 1: Copijnzaal	MDT 2c	Multidisciplinary team workshop – Imaging and staging: cases on T-staging and treatment decision (surveillance / surgery) Geert Villiers, Gent Lisa Tarlington, Sydney
Room 6: Johan de Meersterzaal	MDT 3c	Multidisciplinary team workshop – Imaging and staging: cases on N/M-staging and treatment decision (surgery/radiation/systemic treatment) Giueseppe Petralia, Milan Joe Busch, USA
Room 7: Hans Kazànzaal	MDT 4c	Multidisciplinary team workshop – Imaging and radiation: cases on indication, GTV/CTV, and focal boosting (radiation) Floris Pos, Amsterdam Patrik Zamecnik, Nijmegen Harm van Melick, Utrecht Uulke van der heide, Amsterdam
12:45 – 12:50		Summary and closing
13:00 – 14:00		Lunch

VENUE

Het Rond 2

3701

HS Zeist

VENUE

Contact

Organising Secretariat

+34 960 72 82 12
courses(at)esur.org

PROGRAMME

Day 3 (Saturday) features a half-day program with parallel sessions. Participants can choose between lectures on the Organization of Diagnostic Prostate Cancer Care and Screening, or engage in CBP–workshops, MTD–presentations, or HOT–workshops that cover all previously presented topics.

27th June Thursday

08:00 – 09:00

Registration, coffee

08:45 – 08:50

Welcome

08:50 – 09:40

Prostate MRI in diagnosis

09:40 – 10:30

MRI challenges: Benefit/harms, acquisition, and quality

10:30 – 11:00

Coffee/Tea break

11:00 – 11:50

MRI challenges: Contrast, PI-RADS 3, interobserver varaibility, ADC quantification

11:50 – 12:40

MRI challenges: Risk assessment, biopsy, histology analysis

12:40 – 13:40

Industry Lunch Symposium

Parallel session / workshops

15:45 – 16:15

Coffee/Tea break

16:15 – 17:05

MRI in Active Surveillance

17:05 – 17:15

Summary and closing

13:40 – 14:40 Parallel session / workshops

Room 1: Copijnzaal

RW 1a

Radiological workshop – Prostate MRI: cases (5-10) on PI-RADS assessment

Room 2: Springerzaal

RW 2a

Radiological workshop – Prostate MRI: cases (5-10) on notorious pitfalls and tricks

Room 3: Zocherzaal

HOT 1

Hands-on training (a) (24 people)

Room 4: Tersteegzal

HOT 2

Hands-on training (b) (24 people)

Room 5: Willem Pijperzaal

MDT 1a

Multi-disciplinary (MDT) team workshop – MRI and biopsy: Case-discussion on risk stratification and biopsy decision

Room 6: Johan de Meersterzaal

RW 3a

Radiological workshop – MRI quality: cases (5-10) on PI-QUAL in daily practice

Room 7: Hans Kazànzaal

RW 4a

Radiological case-based workshop – MRI challenges: cases on indeterminate scans

14:40 – 14:45

Change Rooms

14:45 – 15:45 Parallel session / workshops

Room 1: Copijnzaal

RW 1b

Radiological workshop – Prostate MRI: cases (5-10) on PI-RADS assessment

Room 2: Springerzaal

RW 2b

Radiological workshop – Prostate MRI: cases (5-10) on notorious pitfalls and tricks

Room 3: Zocherzaal

HOT 3

Hands-on training (a) (24 people)

Room 4: Tersteegzal

HOT 4

Hands-on training (b) (24 people)

Room 5: Willem Pijperzaal

MDT 1b

Multi-disciplinary (MDT) team workshop – MRI and biopsy: Case-discussion on risk stratification and biopsy decision

Room 6: Johan de Meersterzaal

RW 3b

Radiological workshop – MRI quality: cases (5-10) on PI-QUAL in daily practice

Room 7: Hans Kazànzaal

RW 4b

Radiological case-based workshop – MRI challenges: cases on indeterminate scans

28th June Friday

08:00 – 09:00

Registration, coffee

08:30 – 08:35

Welcome

08:35 – 09:25

Imaging in locally advanced prostate cancer: T-staging and treatment decisions

Geert Villiers, GentHenk van der Poel, Amsterdam

Geert Villiers, Gent
Henk van der Poel, Amsterdam

Giueseppe Petralia, Milan
James Nagarajah, Dusseldorf